Published in
Elsevier, Lancet Gastroenterology and Hepatology, 5(5), p. 441-453, 2020
DOI: 10.1016/s2468-1253(19)30421-2
Links
Tools
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Journal article published in 2020 by
Pietro Lampertico,
Maria Buti 
,
Scott Fung,
Sang Hoon Ahn,
Wan-Long Chuang,
Won Young Tak,
Alnoor Ramji,
Chi-Yi Chen,
Edward Tam,
Ho Bae,
Xiaoli Ma,
John F. Flaherty,
Anuj Gaggar,
Audrey Lau,
Yang Liu
and other authors.
,
Scott Fung,
Sang Hoon Ahn,
Wan-Long Chuang,
Won Young Tak,
Alnoor Ramji,
Chi-Yi Chen,
Edward Tam,
Ho Bae,
Xiaoli Ma,
John F. Flaherty,
Anuj Gaggar,
Audrey Lau,
Yang Liu
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 